Positron emission tomography in patients with glioma a predictor of prognosis
暂无分享,去创建一个
Abass Alavi | Martin Reivich | John Powe | A. Alavi | M. Reivich | J. Chawluk | J. Alavi | M. Kushner | Jane B. Alavi | John Chawluk | Michael Kushner | William Hickey | J. Powe | W. Hickey
[1] S. Green,et al. Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.
[2] R. Brooks,et al. Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. , 1983, AJNR. American journal of neuroradiology.
[3] A. Alavi,et al. Positron emission tomography imaging of regional cerebral glucose metabolism. , 1986, Seminars in nuclear medicine.
[4] G Di Chiro,et al. Prediction of survival in glioma patients by means of positron emission tomography. , 1985, Journal of neurosurgery.
[5] Elisa T. Lee,et al. Statistical Methods for Survival Data Analysis , 1994, IEEE Transactions on Reliability.
[6] C. S. Higgins,et al. Design considerations for a positron emission transverse tomograph (PETT V) for imaging of the brain. , 1978, Journal of computer assisted tomography.
[7] R A Brooks,et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography , 1982, Neurology.
[8] R. G. Manning,et al. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. , 1982, Radiology.
[9] A. Alavi,et al. The [18F]Fluorodeoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization in Mane , 1979, Circulation research.
[10] D. Schoenfeld,et al. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas , 1983, Cancer.